Skip to content

Mavrilimumab

Mavrilimumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor receptor subunit alpha.
Trade Name
Common Name Mavrilimumab
Indication
Drug Class Monoclonal antibodies
Mavrilimumab
Get full access now